leisure time -WSS

leisure time

author：explore 2025-10-01 15:30:21 - browse：438

Transparent plastic divider on the reception desk in the hospital admission department with red lettering emergency. — Adobe

QuidelOrtho has recalled nearly 8,000 potentially faulty blood tests meant to help doctors quickly determine whether a patient is having a heart attack.

The tests inaccurately showed low levels of troponin, a protein that indicates damage to the heart. A false negative could lead doctors to mistakenly conclude their patient is not having a heart attack, delaying diagnosis or treatment when time is of the essence.

The device maker, which also sells products like the QuickVue Covid-19 antigen test, sent letters to health systems in May telling them to immediately stop using the test. The Food and Drug Administration classified the recall as serious, because problems with the product could result in serious injury or death. QuidelOrtho has reported 41 complaints, but no injuries or deaths so far.

The tests, which use either a blood or plasma sample, promise to return results in under half an hour. They are used in emergency rooms to triage patients suspected of having a heart attack.

Related: With Wegovy and Ozempic’s success, can device makers keep up in the race to treat obesity?

The FDA said the patients most at risk are those with zero or abnormal heart attack symptoms, for whom a diagnosis would be easy to miss without an accurate lab test.

The company advised using a different testing method to detect heart attacks. If none are available, doctors should be extra wary of the blood panel’s readings, perform multiple tests to confirm low troponin levels, and also reference data from EKGs and other imaging.

San Diego-based QuidelOrtho said the error is due to a “raw material issue” in its recall record. The issue caused the test to falsely pick up 30% less troponin than is present. The company did not respond to STAT’s request for more information on the error.

The test maker’s last serious recall was in 2021 for reports of false negatives from its Lyra PCR Covid-19 test when used with certain lab equipment. The notice impacted more than 18,000 test kits.

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： How Robert F. Kennedy Jr. distorted vaccine science

hotspot

WSS

Lupron, used to halt puberty in children, may cause lasting health problems

Drug cartel violence flares in western Mexico after vigilante leader's killing

TikTok cracks down on users posting about weight loss drugs

The kidney, in all its complexity, is captured in a new atlas

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

hotspot

leisure time

Related: With Wegovy and Ozempic’s success, can device makers keep up in the race to treat obesity?

focus

Medicare proposal to cover medical devices draws a mixed reaction

Celebrate National Dole Whip Day for 3 days this week at Disney

Virginia high school admissions case could be legal follow

TikTok cracks down on users posting about weight loss drugs

George Santos makes 1st court appearance after pleading not guilty to 13 counts

'Reaching a detente': STAT's Helen Branswell on covering Covid

Jerome Adams on the need for new antivirals for Covid

Hubble vs. James Webb telescope images: See the difference

After affirmative action ruling, medical educators look to 'holistic review'

Canadians with cystic fibrosis outlive Americans by a decade

focus

Use doctors trained outside the U.S. to ease the physician shortage

Stanford president to resign after investigation of research

Drug cartel violence flares in western Mexico after vigilante leader's killing

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

The biotech scorecard for Q3: 15 stock

How dance can help health care workers heal from trauma

focus

entertainment

hotspot

knowledge